ClinicalTrials.gg
CompletedNCT04302610Updated Mar 10, 2020

Do Heat and Moisture Exchange Mask Reduce EIB and Cough Severity in Asthma

An interventional study of Heat and Moisture Exchange mask (ColdAvenger® expedition balaclava, USA, and Sham treatment in Asthma, Exercise-Induced and Asthma, sponsored by University of Kent. Completed. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2020-03-10.

Sponsored by University of Kent · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 3 years 6 months after the study started (first participant enrolled Sep 2016, registered Mar 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The overall aim of this study is to determine if face masks that can warm and humidify air can improve overall asthma control and markers of airway health during exercise in cold dry environments. We will investigate the potential protective benefits of the face masks against exercise induced asthma during 1) a "one-off" bout of exercise in a cold dry environment and 2) over the course of a four week period, exercising three times per week in a cold dry environment.

Read the detailed description

Physical activity is recognised as a trigger for individuals with asthma, however regular physical activity is considered to be important in the overall management of the condition. There is clear evidence that demonstrates if individuals with asthma engage with regular physical activity they will improve their physical fitness and breathing control, whilst at the same time experiencing reductions in asthma severity, symptoms, and medication use. In addition undertaking regular exercise reduces the risk of developing other diseases such as heart disease or type 2 diabetes. Despite the clear health benefits of engaging in regular physical activity there is evidence that some people with asthma avoid physical activity due to shortness of breath, worsening asthma symptoms during physical activity or fear of experiencing such symptoms.

Physical activity in cold dry environments exacerbates symptoms for many individuals with asthma resulting in greater avoidance of physical activity during the winter months. The increased risk of asthma from exercising in cold environments has led to Asthma UK advising susceptible individuals to avoid exercise outside in cold environments (http://www.asthma.org.uk/advice-exercise). This places obvious constraints and limitations on individuals with asthma for whom the aim of optimum treatment is to allow them to follow a "normal" lifestyle. Indeed, exposure to cold air on exertion is relevant to a significant proportion of individuals with asthma who engage with outdoor physical activity as part of their daily routine; e.g. cycle-commuting to work, outdoor construction workers.

A mask that is able to warm and humidify the air during exercise may provide a solution for asthmatic individuals susceptible to cold dry environments. There are a limited number of small studies that provide tentative evidence suggesting masks which warm and humidify air can protect against reductions in lung function during and following physical activity. However, it is unknown whether the use of these masks provides protection against the mechanisms that drive asthmatic symptoms. It is also unclear whether using the masks over a prolonged period of time significantly reduces asthma severity, inhaler use, or presence of symptoms.

The overall aim of this study is to determine if face masks that can warm and humidify air can improve overall asthma control and markers of airway health during exercise in cold dry environments. We will investigate the potential protective benefits of the face masks against exercise induced asthma during 1) a "one-off" bout of exercise in a cold dry environment and 2) over the course of a four week period, exercising three times per week in a cold dry environme

02

Conditions studied

  • Asthma, Exercise-Induced
  • Asthma
03

In context

Asthma, Exercise-Induced

52 studies on the registry are indexed under Asthma, Exercise-Induced; 3 are open to participants now.

This study's enrollment of 26 is below the median of 47 across 40 interventional studies indexed under Asthma, Exercise-Induced.

Browse Asthma, Exercise-Induced studies →

Lead sponsor

University of Kent is the lead sponsor of 7 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ability to consent to the research
  • Prior clinician based diagnosis of asthma
  • Males and females
  • 18 - 45 years
  • Engage in regular exercise (at least twice weekly)
  • Normal resting (FEV1); defined as greater than 80% of predicted value.

Exclusion criteria

Exclusion Criteria:

  • Chest infection within the past 4 weeks, or any other illness within the past 2 weeks
  • Fall in >50% from baseline following exercise challenge (see protocol)
  • Baseline FEV1 of \< 80% of predicted
  • Cardiovascular conditions:

    • Coronary Artery Disease
    • High Blood Pressure
    • Heart Failure
    • Diagnosed Abnormality of Heart Rhythm
  • Metabolic diseases:

    • Type 1 diabetes
    • Type 2 diabetes
    • Pre-diabetes
  • Daily use of oral
  • Hospitalisation due to asthma in the six months prior to study commencement
  • Injury or conditions that limit mobility
  • Pregnancy
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

FEV1

From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    HME MASK

    During the Exercise, participants wore either an HME mask (MASK) (ColdAvenger® expedition balaclava, USA, www.coldavenger.com)

    Device: Heat and Moisture Exchange mask (ColdAvenger® expedition balaclava, USA,

  • Sham comparator
    SHAM mask

    a sham mask (SHAM) which was the same HME mask with holes cut across the entire ventilator cup and the ventilator removed

    Device: Sham treatment

  • No intervention
    Control

    No mask (CONT) wearing only the balaclava to which the HME and SHAM mask were attached. Mouth and face not covered.

Interventions

  • DeviceHeat and Moisture Exchange mask (ColdAvenger® expedition balaclava, USA,

    A heat and moisture exchange mask will warm and humidify inspired air and therefore reduce airway heat and water loss during exercise. This will potentially reduce the incidence of and severity of EIB and may also have the potential to decrease the incidence of cough amongst athletes engaging in sports in cold dry environments

  • DeviceSham treatment

    Same as the HME mask but active HME parts withdrawn from devices and multiple holes made in mouth piece to improve ventilation of mask and reduce HME ability of mask

06

What researchers measure

Primary outcomes

  1. % fall in FEV1

    Change in Forced Expiratory Volume in One Second from baseline to post exercise

    Time frame: 30 minutes

Secondary outcomes

  1. coughs per hour after EX

    Number of coughs per hour in a 24 hour period after exercise

    Time frame: 24 hours

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2016 to primary completion in Apr 2018, 19 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 6, 2020
First posted
Mar 10, 2020
StartActual
Sep 1, 2016
Primary completionActual
Apr 1, 2018
CompletionActual
May 15, 2018
Last update
Mar 10, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 10, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04302610
Lead sponsor
University of Kent
Responsible party
Sponsor
First posted
Mar 10, 2020
Start date
Sep 1, 2016
Primary completion
Apr 1, 2018
Completion
May 15, 2018
Last update
Mar 10, 2020

Study contacts

John W Dickinson, PhD
principal investigator · University of Kent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion